Evidence map›Paper›PMID 17079304›Full record

ArticleJournal of virology2007

The varicella-zoster virus (VZV) ORF9 protein interacts with the IE62 major VZV transactivator.

Cristian Cilloniz, Wallen Jackson, Charles Grose, Donna Czechowski, John Hay, William T Ruyechan

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Simian varicella virus: molecular virology.Current topics in microbiology and immunology · 2010
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Cristian CillonizDepartment of Microbiology, Witebsky Center for Microbial Pathogenesis and Immunology, University at Buffalo, SUNY, Buffalo, NY 14214, USA.
Wallen Jackson
Charles Grose
Donna Czechowski
John Hay
William T Ruyechan
University at Buffalo, State University of New York · USUniversity of Iowa · US

Funding

Varicella-zoster Virus: Tegument Proteins in PathogenesisR01AI053846 · NIAID · STANFORD UNIVERSITY · PI ARVIN, ANN · 2003 to 2012
$4.1M
Structure/Function of Varicella Zoster Virus DNAR01AI018449 · NIAID · U.S. UNIFORMED SERVICES UNIV OF HLTH SCI · PI RUYECHAN, WILLIAM T · 1985 to 2007
$1.8M
Structure/Function of Varicella Zoster Virus DNA.R56AI018449 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI HAY, JOHN I. · 2008 to 2009
$788k
Structure/Function of Varicella Zoster Virus DNAR21AI018449 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI RUYECHAN, WILLIAM T · 2002 to 2002
$304k
NIAID NIH HHS AI053846NIAID NIH HHS AI18449NIAID NIH HHS R01 AI018449NIAID NIH HHS R01 AI053846NIAID NIH HHS R21 AI018449NIAID NIH HHS R56 AI018449
6 · The paper itself

Abstract

The varicella-zoster virus (VZV) ORF9 protein is a member of the herpesvirus UL49 gene family but shares limited identity and similarity with the UL49 prototype, herpes simplex virus type 1 VP22. ORF9 mRNA is the most abundantly expressed message during VZV infection; however, little is known concerning the functions of the ORF9 protein. We have found that the VZV major transactivator IE62 and the ORF9 protein can be coprecipitated from infected cells. Yeast two-hybrid analysis localized the region of the ORF9 protein required for interaction with IE62 to the middle third of the protein encompassing amino acids 117 to 186. Protein pull-down assays with GST-IE62 fusion proteins containing N-terminal IE62 sequences showed that amino acids 1 to 43 of the acidic transcriptional activation domain of IE62 can bind recombinant ORF9 protein. Confocal microscopy of transiently transfected cells showed that in the absence of other viral proteins, the ORF9 protein was localized in the cytoplasm while IE62 was localized in the nucleus. In VZV-infected cells, the ORF9 protein was localized to the cytoplasm whereas IE62 exhibited both nuclear and cytoplasmic localization. Cotransfection of plasmids expressing ORF9, IE62, and the viral ORF66 kinase resulted in significant colocalization of ORF9 and IE62 in the cytoplasm. Coimmunoprecipitation experiments with antitubulin antibodies indicate the presence of ORF9-IE62-tubulin complexes in infected cells. Colocalization of ORF9 and tubulin in transfected cells was visualized by confocal microscopy. These data suggest a model for ORF9 protein function involving complex formation with IE62 and possibly other tegument proteins in the cytoplasm at late times in infection.

Indexed as

Amino Acid SequenceAnimalsCell Line, TumorChlorocebus aethiopsCytoplasmHerpesvirus 3, HumanHumansImmediate-Early ProteinsMicroscopy, ConfocalMolecular Sequence DataOpen Reading FramesSequence AlignmentTrans-ActivatorsTubulinVero CellsViral Envelope Proteinsherpes simplex virus type 1 protein VP22IE62 protein, Human herpesvirus 3Immediate-Early ProteinsTrans-ActivatorsTubulinViral Envelope ProteinsViral ProteinsViral Structural Proteins

Identifiers

PMID17079304
PMCPMC1797441
OpenAlexW2052267129

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.